medmix AG (MEDX) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.50x
medmix AG (MEDX) has a Cash Flow Reinvestment Rate of 0.50x as of December 2025, reinvesting CHF18.80 Million (capex CHF18.80 Million ) from operating cash flow of CHF37.40 Million. Explore MEDX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.50x
(Capex + Investments) / Operating CF
Total Reinvested
CHF18.80 Million
Capex + Investments
Operating Cash Flow
CHF37.40 Million
CHF
Capital Expenditures
CHF18.80 Million
CHF
medmix AG Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for medmix AG across 8 annual periods. Also explore medmix AG (MEDX) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for medmix AG (2018–2025)
Year-by-year capital reinvestment analysis for medmix AG. For live market cap and broader valuation context, see MEDX stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CHF34.50 Million | CHF67.80 Million | CHF34.50 Million | ▼ -55.9% |
| 2024 | 1.15x | CHF100.00 Million | CHF86.60 Million | CHF48.50 Million | ▼ -51.5% |
| 2023 | 2.38x | CHF133.50 Million | CHF56.10 Million | CHF52.90 Million | ▲ +18.5% |
| 2022 | 2.01x | CHF95.60 Million | CHF47.60 Million | CHF38.60 Million | ▲ +177.9% |
| 2021 | 0.72x | CHF63.10 Million | CHF87.30 Million | CHF31.90 Million | ▼ -57.8% |
| 2020 | 1.71x | CHF86.60 Million | CHF50.60 Million | CHF43.10 Million | ▲ +252.2% |
| 2019 | 0.49x | CHF43.30 Million | CHF89.10 Million | CHF36.20 Million | ▲ +23.4% |
| 2018 | 0.39x | CHF37.10 Million | CHF94.20 Million | CHF30.00 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow